posttransplant tacrolimus-induced diabetic ketoacidosis: review of the literature

Clicks: 319
ID: 131605
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #23 of 81 articles by views in chemosensors

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.
Reference Key
ammari2018caseposttransplant Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Zaid Ammari;Stella C. Pak;Mohammed Ruzieh;Osama Dasa;Abhinav Tiwari;Juan C. Jaume;Maria A. Alfonso-Jaume
Journal chemosensors
Year 2018
DOI
10.1155/2018/4606491
URL
http://dx.doi.org/10.1155/2018/4606491
Keywords
clinical endocrinology diseases of the endocrine glands

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.